ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,721, issued on Aug. 11, was assigned to University of Utah Research Foundation (Salt Lake City).
"Gene therapy for macular degeneration" was invented by Gregory Scott Hageman (Salt Lake City) and Burt Timothy Richards (Midway, Utah).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides compositions and methods for treatment of age-related macular degeneration, including gene therapy employing vectors and transgenes expressing protective CFH polypeptide and CFHT polypeptide sequences."
The patent was filed on July 22, 2019, under Application No. 17/261,559.
*For further information, including images, charts and tables, please visit: ...